OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 42 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $30,890 | -62.7% | 55,095 | -24.2% | 0.00% | – |
Q1 2023 | $82,885 | +76645.4% | 72,664 | -24.4% | 0.00% | – |
Q4 2022 | $108 | -99.9% | 96,151 | +11.3% | 0.00% | – |
Q3 2022 | $182,000 | +83.8% | 86,361 | +18.9% | 0.00% | – |
Q2 2022 | $99,000 | -19.5% | 72,623 | 0.0% | 0.00% | – |
Q1 2022 | $123,000 | +57.7% | 72,623 | 0.0% | 0.00% | – |
Q4 2021 | $78,000 | -64.5% | 72,623 | -2.9% | 0.00% | – |
Q3 2021 | $220,000 | +27.9% | 74,778 | +30.7% | 0.00% | – |
Q2 2021 | $172,000 | -14.4% | 57,225 | -6.6% | 0.00% | – |
Q1 2021 | $201,000 | -20.2% | 61,241 | 0.0% | 0.00% | – |
Q4 2020 | $252,000 | +29.2% | 61,241 | +70.0% | 0.00% | – |
Q3 2020 | $195,000 | +78.9% | 36,021 | +123.0% | 0.00% | – |
Q2 2020 | $109,000 | – | 16,151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 8,148,832 | $8,801,000 | 3.14% |
Rovida Advisors Inc. | 3,000,000 | $3,210,000 | 0.14% |
Zebra Capital Management LLC | 24,384 | $26,000 | 0.04% |
TITLEIST CAPITAL, LLC | 80,184 | $87,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,125,689 | $1,216,000 | 0.01% |
ArrowMark Colorado Holdings LLC | 1,000,000 | $1,080,000 | 0.01% |
Insight Advisors, LLC/ PA | 24,800 | $27,000 | 0.01% |
Renaissance Technologies | 1,355,774 | $1,464,000 | 0.00% |
Engineers Gate Manager LP | 42,810 | $46,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 249,851 | $270,000 | 0.00% |